Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accelerate, acquisition, advisory, ALI, anti, appeal, attenuation, breathing, cascade, CEO, challenging, cleared, COVID, cycle, decision, deferral, degree, destructive, dialog, dissolved, domestic, eligibility, equal, exposure, fatal, Flexibility, fulfilled, great, group, heightened, IAS, impede, induced, inflamed, inhalation, inhaled, Institutional, interrupt, interrupting, intractable, jeopardized, lesser, local, manuscript, maximizing, monthly, movement, mutual, navigate, notice, notify, objective, parallel, partnering, pharmacological, prejudice, prioritization, proceed, promptly, recreation, regional, remit, Safer, shut, Similarly, situation, slightly, sought, spike, statue, steady, strain, strength, supplement, supplemental, Surgery, synergistic, systematic, tract, typically, underserved, Vast
Removed:
announce, assist, aware, biological, cease, charter, closing, commercialize, commercialized, commercializing, community, competition, complex, compliance, considerably, consuming, corporate, cybersecurity, Delaware, delisted, dependent, direct, discovering, dispute, divert, drafted, extremely, face, factual, fail, fluctuate, guarantee, harm, harmed, impair, impose, influence, infrastructure, internationally, investigation, investment, landscape, lean, liable, listing, long, maintenance, manipulation, manufacture, marketed, misappropriation, NYSE, outsource, patent, payor, post, proprietary, realize, receiving, registered, regulated, requesting, stated, streamlining, unanticipated, unfavorable, volatile, vulnerable, withdrawal
Filing tables
Filing exhibits
AMPE similar filings
Filing view
External links
Exhibit 32.1
AMPIO PHARMACEUTICALS, INC.
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended June 30, 2020 (the “Report”) by Ampio Pharmaceuticals, Inc. (the “Company”), each of the undersigned hereby certifies to his knowledge that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Ay 10 | |
Dated: July 31, 2020 | /s/ Michael Macaluso |
| Michael Macaluso |
| Chairman and Chief Executive Officer |
|
|
Dated: July 31, 2020 | /s/ Daniel G. Stokely |
| Daniel G. Stokely |
| Chief Financial Officer, Treasurer and Secretary |